Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prevalence Of Microalbuminuria Among Children Suffering From Sickle Cell Nephropathy and Sickle Cell/Beta-Thalassemia

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2010 by Hillel Yaffe Medical Center.
Recruitment status was  Not yet recruiting
Information provided by:
Hillel Yaffe Medical Center Identifier:
First received: March 23, 2010
Last updated: NA
Last verified: March 2010
History: No changes posted

Sickle cell nephropathy is a known complication of sickle cell anemia (SCA) manifested by increase in glomerular filtration rate (glomerular hyperfiltration) and results in proteinuria and chronic renal failure.

Our goal is to examine the prevalence of proteinuria and microalbuminuria as an early predictive factor of glomerular injury, among young people who suffer from SCA as well as those who suffer from combined sickle cell/beta-thalassemia.

Condition Intervention
Sickle Cell Anemia
Other: No intervention

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional

Resource links provided by NLM:

Further study details as provided by Hillel Yaffe Medical Center:

Groups/Cohorts Assigned Interventions
Sickle cell beta Other: No intervention


Ages Eligible for Study:   up to 25 Years   (Child, Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Young people suffering from SCA as well as those who suffer from combined sickle cell/beta-thalassemia, between 0-25 years old.

Inclusion Criteria:

  • Patients diagnosed with sickle cell anemia
  • Patients diagnosed with combined sickle cell anemia/beta-thalassemia

Exclusion Criteria:

  • Diabetes mellitus
  • Hypertension
  • Reduced renal mass (single kidney)
  • Overweight
  • History of UTIs
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: Amit Hochberg, Pediatrics Department, Hillel Yaffe Medical Center Identifier: NCT01092169     History of Changes
Other Study ID Numbers: 64/2009 
Study First Received: March 23, 2010
Last Updated: March 23, 2010
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Anemia, Sickle Cell
Anemia, Hemolytic, Congenital
Anemia, Hemolytic
Hematologic Diseases
Genetic Diseases, Inborn
Urination Disorders
Urologic Diseases
Urological Manifestations
Signs and Symptoms processed this record on October 21, 2016